EDC-MASLD

EDC-MASLD

Research Services

EU-funded project on Endocrine-Disrupting Chemicals and Metabolic Dysfunction-Associated Steatotic Liver Disease.

About us

EDC-MASLD is an EU-funded project focused on exploring the role of Endocrine-Disrupting Chemicals (EDCs) in the progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). With MASLD affecting 25% of the general population, it’s crucial to understand all contributing factors for effective prevention and intervention. EDC-MASLD investigates the impact of EDCs on the internal exposome across various dimensions (metabolome, gut microbiome, epigenome, proteome, immunome), emphasizing prospective studies during the transition to progressive MASLD stages. Leveraging the rich European NAFLD Registry with over 9,000 characterized patients, the consortium examines the intricate interplay between EDC exposure, sex, genotype, diet, socioeconomic, and lifestyle factors.

Industry
Research Services
Company size
11-50 employees

Updates

Affiliated pages

Similar pages